Background: Maxillary canine impaction can result in malocclusion, temporomandibular joint complications, and esthetic concerns, thus influencing craniofacial development. Although cases of impacted canines are not uncommon in clinical practice, the likelihood of simultaneous bilateral impaction is extremely low; very few reports have documented cases of bilaterally symmetrical, inversely impacted canines.
Case presentation: This paper reports a rare case of maxillary canine impaction, a condition characterized by the abnormal eruption of teeth. Potential causes of this condition include genetic, systemic, and localized factors. We analyzed this condition in the skeletal remains of a Taiwanese girl aged 11-14 years. The skeleton, dating 440-598 AD, was recovered from central Taiwan in 2019. Through panoramic X-ray and dental cone-beam computed tomography, we constructed a three-dimensional model of the skull, which exhibited bilateral symmetrical, inversely impacted maxillary canines-a rare clinical observation. On the basis of the current understanding of the dental field, the treatment of maxillary canine impaction is time consuming and labor intensive. Different impacted canine teeth have different difficulty levels of treatment.
Conclusion: The archaeological data in this article show that 1500 years ago humans already had the problem of impacted canine teeth in the upper jaw. Moreover, bilaterally symmetrical maxillary canine impaction is very rare in clinical cases.
{"title":"Bilateral inverse canine impaction: a case report.","authors":"Tzu-Yuan Weng, Shiuan-Hui Wang, Chih-Cheng Chen, Lih-Jyh Fuh, Ke-Hung Liu, Jui-Ting Hsu","doi":"10.1186/s13256-024-04977-3","DOIUrl":"10.1186/s13256-024-04977-3","url":null,"abstract":"<p><strong>Background: </strong>Maxillary canine impaction can result in malocclusion, temporomandibular joint complications, and esthetic concerns, thus influencing craniofacial development. Although cases of impacted canines are not uncommon in clinical practice, the likelihood of simultaneous bilateral impaction is extremely low; very few reports have documented cases of bilaterally symmetrical, inversely impacted canines.</p><p><strong>Case presentation: </strong>This paper reports a rare case of maxillary canine impaction, a condition characterized by the abnormal eruption of teeth. Potential causes of this condition include genetic, systemic, and localized factors. We analyzed this condition in the skeletal remains of a Taiwanese girl aged 11-14 years. The skeleton, dating 440-598 AD, was recovered from central Taiwan in 2019. Through panoramic X-ray and dental cone-beam computed tomography, we constructed a three-dimensional model of the skull, which exhibited bilateral symmetrical, inversely impacted maxillary canines-a rare clinical observation. On the basis of the current understanding of the dental field, the treatment of maxillary canine impaction is time consuming and labor intensive. Different impacted canine teeth have different difficulty levels of treatment.</p><p><strong>Conclusion: </strong>The archaeological data in this article show that 1500 years ago humans already had the problem of impacted canine teeth in the upper jaw. Moreover, bilaterally symmetrical maxillary canine impaction is very rare in clinical cases.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":"18 1","pages":"617"},"PeriodicalIF":0.9,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11686836/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142907130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-31DOI: 10.1186/s13256-024-05009-w
Xianglin Wu, Mingzhu Zhai, Aohong Xu, Yi Zheng
Background: Idiopathic CD4+ T lymphocytopenia is a rare immune dysfunction disease that is usually found after opportunistic infections. Mycobacterium abscessus is a rapidly growing mycobacterium that can cause pulmonary infections, lymphadenitis, skin and soft tissue infections, disseminated infections, among others, as a conditional pathogenic bacterium.
Case presentation: We present the case of a 43-year-old Chinese woman who developed disseminated Mycobacterium abscessus infection due to idiopathic CD4+ T lymphocytopenia. The patient exhibited symptoms including skin infections, lymphadenitis, and bacteremia. A tailored multidrug therapy was initiated, guided by drug susceptibility testing. Within a month of treatment, the patient's fever resolved, and she exhibited a significant recovery and was discharged.
Conclusions: Cases of clinical idiopathic CD4+ T lymphocytopenia with Mycobacterium abscessus infection are not common. Clinicians should be vigilant and accurately identify Mycobacterium abscessus as an opportunistic pathogen when dealing with immunocompromised patients, in particular with idiopathic CD4+ T lymphocytopenia.
{"title":"Disseminated Mycobacterium abscessus infection with idiopathic CD4+ T-lymphocytopenia: a case report and review of the literature.","authors":"Xianglin Wu, Mingzhu Zhai, Aohong Xu, Yi Zheng","doi":"10.1186/s13256-024-05009-w","DOIUrl":"10.1186/s13256-024-05009-w","url":null,"abstract":"<p><strong>Background: </strong>Idiopathic CD4+ T lymphocytopenia is a rare immune dysfunction disease that is usually found after opportunistic infections. Mycobacterium abscessus is a rapidly growing mycobacterium that can cause pulmonary infections, lymphadenitis, skin and soft tissue infections, disseminated infections, among others, as a conditional pathogenic bacterium.</p><p><strong>Case presentation: </strong>We present the case of a 43-year-old Chinese woman who developed disseminated Mycobacterium abscessus infection due to idiopathic CD4+ T lymphocytopenia. The patient exhibited symptoms including skin infections, lymphadenitis, and bacteremia. A tailored multidrug therapy was initiated, guided by drug susceptibility testing. Within a month of treatment, the patient's fever resolved, and she exhibited a significant recovery and was discharged.</p><p><strong>Conclusions: </strong>Cases of clinical idiopathic CD4+ T lymphocytopenia with Mycobacterium abscessus infection are not common. Clinicians should be vigilant and accurately identify Mycobacterium abscessus as an opportunistic pathogen when dealing with immunocompromised patients, in particular with idiopathic CD4+ T lymphocytopenia.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":"18 1","pages":"645"},"PeriodicalIF":0.9,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11687038/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142909686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Ectopic pregnancy, occurring outside the uterine cavity, poses a significant health risk, with Fallopian tube involvement being predominant. Recurrent ectopic pregnancy, particularly in the ipsilateral remnant of a previously removed tube, is a rare and poorly understood phenomenon. Here, we present a case of recurrent ectopic pregnancy occurring in the distal remnant of the right fallopian tube following ipsilateral incomplete salpingectomy in a 22-year-old woman.
Case presentation: A 22-year-old woman of mixed Arab ancestry and African ethnicity, gravida 4, para 1, with a history of one miscarriage and a previous ectopic pregnancy, presented to Elshatby Maternity Hospital, Alexandria, Egypt, complaining of severe lower abdominal pain with a history of an open right salpingectomy one year prior due to the ectopic pregnancy. She exhibited stable vital signs on admission. Ultrasound revealed a 6-week gestational sac in the right fallopian tube, accompanied by hematoma and mild pelvic collection. Despite analgesic interventions, her symptoms worsened the next day, prompting open surgery. Surprisingly, the distal portion of the right tube, which was supposed to have been removed in the prior salpingectomy, contained the ectopic pregnancy. A laparotomy was performed, involving evacuation of the pelvic hematoma, distal ipsilateral tubal salpingectomy, and peritoneal lavage. Postoperative recovery was uneventful, with improvement demonstrated during follow-up.
Conclusion: Caution should be taken when dealing with any woman in the reproductive age group who presents with acute abdomen, especially if she has a previous history of ectopic pregnancy, to exclude the possibility of recurrent ectopic pregnancy. Previous salpingectomy does not exclude the possibility of recurrent ectopic pregnancy on the ipsilateral side, as the inappropriate surgical technique used during salpingectomy can affect the possibility of recurrence. We suggest that careful clinical consideration of the surgical technique used during salpingectomy is essential to minimize the risk of recurrent ectopic pregnancies and prevent serious complications.
{"title":"Ipsilateral ectopic pregnancy in the distal remaining part of the previously removed Fallopian tube: a case report.","authors":"Bassant Elshatby, Mohamed Mohamed Belal, Mohamed Emad Rezk","doi":"10.1186/s13256-024-04893-6","DOIUrl":"10.1186/s13256-024-04893-6","url":null,"abstract":"<p><strong>Background: </strong>Ectopic pregnancy, occurring outside the uterine cavity, poses a significant health risk, with Fallopian tube involvement being predominant. Recurrent ectopic pregnancy, particularly in the ipsilateral remnant of a previously removed tube, is a rare and poorly understood phenomenon. Here, we present a case of recurrent ectopic pregnancy occurring in the distal remnant of the right fallopian tube following ipsilateral incomplete salpingectomy in a 22-year-old woman.</p><p><strong>Case presentation: </strong>A 22-year-old woman of mixed Arab ancestry and African ethnicity, gravida 4, para 1, with a history of one miscarriage and a previous ectopic pregnancy, presented to Elshatby Maternity Hospital, Alexandria, Egypt, complaining of severe lower abdominal pain with a history of an open right salpingectomy one year prior due to the ectopic pregnancy. She exhibited stable vital signs on admission. Ultrasound revealed a 6-week gestational sac in the right fallopian tube, accompanied by hematoma and mild pelvic collection. Despite analgesic interventions, her symptoms worsened the next day, prompting open surgery. Surprisingly, the distal portion of the right tube, which was supposed to have been removed in the prior salpingectomy, contained the ectopic pregnancy. A laparotomy was performed, involving evacuation of the pelvic hematoma, distal ipsilateral tubal salpingectomy, and peritoneal lavage. Postoperative recovery was uneventful, with improvement demonstrated during follow-up.</p><p><strong>Conclusion: </strong>Caution should be taken when dealing with any woman in the reproductive age group who presents with acute abdomen, especially if she has a previous history of ectopic pregnancy, to exclude the possibility of recurrent ectopic pregnancy. Previous salpingectomy does not exclude the possibility of recurrent ectopic pregnancy on the ipsilateral side, as the inappropriate surgical technique used during salpingectomy can affect the possibility of recurrence. We suggest that careful clinical consideration of the surgical technique used during salpingectomy is essential to minimize the risk of recurrent ectopic pregnancies and prevent serious complications.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":"18 1","pages":"644"},"PeriodicalIF":0.9,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11686981/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142907133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Severe acute respiratory syndrome coronavirus 2 was found first in Wuhan and declared a pandemic by the World Health Organization. Coinfection with other respiratory viruses may occur, complicating the diagnosis and treatment of coronavirus disease 2019 . Herein, we identified a Karolinska Institute polyomavirus Stockholm 60 present in a nasopharyngeal swab of a patient with severe acute respiratory syndrome coronavirus 2 infection using next-generation sequencing with an enrichment method.
Case presentation: A 24-year-old Indonesian woman was admitted to our institution due to a cough, cold, and sore throat. She had no family history of hypertension and diabetes mellitus, and she was well. Her vital signs were as follows: heart rate, 84 beats per minute; respiratory rate, 22 breaths per minute; temperature, 39 °C; and pulse oximetry, 96% on room air. She had runny nose and slightly inflamed pharynx. Her nasopharyngeal swab and real-time polymerase chain reaction were positive for the coronavirus disease 2019 nucleocapsid and open reading frame genes, with cycle threshold values of 32.33 and 33.74, respectively. Whole-genome sequencing of severe acute respiratory syndrome coronavirus 2 was performed using the Nextera DNA Flex for Enrichment using the Respiratory Virus Oligos Panel, Illumina MiSeq instruments, and Illumina MiSeq reagent v3 150 cycles (2 × 75 cycles). The full genomes were aligned to the reference genome (NC_045512.2) by the Burrow-Wheeler aligner algorithm. The whole-genome sequencing showed coinfection of Karolinska Institute polyomavirus Stockholm 60 (NC_009238.1) with an overall coverage of 3561x. The patient was given acetaminophen, vitamin C, vitamin D, and zinc for the treatment and discharged uneventfully from the hospital 4 days after admission. Then, 2 weeks after discharge, she visited the outpatient clinic without any further concerns.
Conclusion: This report presents a case of Karolinska Institute polyomavirus and severe acute respiratory syndrome coronavirus 2 coinfection in a patient with nonspecific clinical manifestation. Further studies with a larger sample size are mandatory to clarify the association between severe acute respiratory syndrome coronavirus 2 and Karolinska Institute polyomavirus coinfection, particularly on patient outcomes. Moreover, the results propose the usefulness of enrichment-based next-generation sequencing in detecting viral coinfection in patients with severe acute respiratory syndrome coronavirus 2.
背景:严重急性呼吸综合征(sars)冠状病毒2型首先在武汉发现,并被世界卫生组织宣布为大流行。可能与其他呼吸道病毒合并感染,使2019冠状病毒病的诊断和治疗复杂化。在此,我们使用新一代测序富集法在严重急性呼吸综合征冠状病毒2感染患者的鼻咽拭子中发现了一种卡罗林斯卡研究所多瘤病毒斯德哥尔摩60。病例介绍:一名24岁的印度尼西亚妇女因咳嗽、感冒和喉咙痛而入院。无高血压及糖尿病家族史,身体健康。她的生命体征如下:心率,每分钟84次;呼吸频率,每分钟22次;温度:39℃;脉搏血氧饱和度,96%是室内空气。她流鼻涕,喉咙有点发炎。鼻咽拭子和实时聚合酶链反应检测结果显示,2019冠状病毒病核衣壳和开放阅读框基因阳性,周期阈值分别为32.33和33.74。使用Nextera DNA Flex for Enrichment,使用respiratory Virus Oligos Panel、Illumina MiSeq仪器和Illumina MiSeq试剂v3 150循环(2 × 75循环)对严重急性呼吸综合征冠状病毒2进行全基因组测序。利用Burrow-Wheeler比对算法将全基因组与参考基因组NC_045512.2进行比对。全基因组测序显示共感染Karolinska Institute多瘤病毒斯德哥尔摩60 (NC_009238.1),总覆盖率为3561x。患者给予对乙酰氨基酚、维生素C、维生素D、锌治疗,入院4天后顺利出院。然后,出院2周后,她去了门诊,没有任何进一步的担忧。结论:本报告报告了一例无特异性临床表现的卡罗林斯卡研究所多瘤病毒和严重急性呼吸综合征冠状病毒2型合并感染患者。必须进行更大样本量的进一步研究,以澄清严重急性呼吸综合征冠状病毒2与卡罗林斯卡研究所多瘤病毒合并感染之间的关系,特别是在患者预后方面。此外,结果表明基于富集的新一代测序在检测严重急性呼吸综合征冠状病毒2患者的病毒合并感染方面是有用的。
{"title":"Coinfection of severe acute respiratory syndrome coronavirus 2 and polyomavirus in a patient with coronavirus disease 2019 detected by enrichment next-generation sequencing: a case report.","authors":"Gunadi, Esensi Tarian Geometri, Pramana Adhityo, Ali Zainal Abidin, Marcellus, Dyah Ayu Puspitarani, Fadila Dyah Trie Utami, Kristy Iskandar, Hendra Wibawa, Mohamad Saifudin Hakim","doi":"10.1186/s13256-024-05005-0","DOIUrl":"10.1186/s13256-024-05005-0","url":null,"abstract":"<p><strong>Background: </strong>Severe acute respiratory syndrome coronavirus 2 was found first in Wuhan and declared a pandemic by the World Health Organization. Coinfection with other respiratory viruses may occur, complicating the diagnosis and treatment of coronavirus disease 2019 . Herein, we identified a Karolinska Institute polyomavirus Stockholm 60 present in a nasopharyngeal swab of a patient with severe acute respiratory syndrome coronavirus 2 infection using next-generation sequencing with an enrichment method.</p><p><strong>Case presentation: </strong>A 24-year-old Indonesian woman was admitted to our institution due to a cough, cold, and sore throat. She had no family history of hypertension and diabetes mellitus, and she was well. Her vital signs were as follows: heart rate, 84 beats per minute; respiratory rate, 22 breaths per minute; temperature, 39 °C; and pulse oximetry, 96% on room air. She had runny nose and slightly inflamed pharynx. Her nasopharyngeal swab and real-time polymerase chain reaction were positive for the coronavirus disease 2019 nucleocapsid and open reading frame genes, with cycle threshold values of 32.33 and 33.74, respectively. Whole-genome sequencing of severe acute respiratory syndrome coronavirus 2 was performed using the Nextera DNA Flex for Enrichment using the Respiratory Virus Oligos Panel, Illumina MiSeq instruments, and Illumina MiSeq reagent v3 150 cycles (2 × 75 cycles). The full genomes were aligned to the reference genome (NC_045512.2) by the Burrow-Wheeler aligner algorithm. The whole-genome sequencing showed coinfection of Karolinska Institute polyomavirus Stockholm 60 (NC_009238.1) with an overall coverage of 3561x. The patient was given acetaminophen, vitamin C, vitamin D, and zinc for the treatment and discharged uneventfully from the hospital 4 days after admission. Then, 2 weeks after discharge, she visited the outpatient clinic without any further concerns.</p><p><strong>Conclusion: </strong>This report presents a case of Karolinska Institute polyomavirus and severe acute respiratory syndrome coronavirus 2 coinfection in a patient with nonspecific clinical manifestation. Further studies with a larger sample size are mandatory to clarify the association between severe acute respiratory syndrome coronavirus 2 and Karolinska Institute polyomavirus coinfection, particularly on patient outcomes. Moreover, the results propose the usefulness of enrichment-based next-generation sequencing in detecting viral coinfection in patients with severe acute respiratory syndrome coronavirus 2.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":"18 1","pages":"646"},"PeriodicalIF":0.9,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11686832/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142909683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-30DOI: 10.1186/s13256-024-04988-0
Habtamu Mesele Gebray, Addisu Liknaw Chekol
<p><strong>Introduction: </strong>Aluminum phosphide is a cheap and commonly used rodenticide that is also an effective solid fumigant and frequently used for grain preservation. The pill contains around 44% inert elements (ammonium carbonate) to avoid disintegration of the tablet, while the rest (about 56%) is aluminum phosphide. Because it is freely available on the market, it is one of the commonly used agents for self-poisoning in different parts of the developing world. Early signs of toxicity are manifested by shock and circulatory failure. Until now, no specific antidote is available. Aggressive supportive management is the key to survival in cases of aluminum phosphide poisoning.</p><p><strong>Case presentation: </strong>We present a case of successful management of aluminum phosphide poisoning-induced cardiotoxicity with a favorable outcome in a 48-year-old Black African female patient who was taken to a private clinic 6 hours after intentional ingestion of two tablets of aluminum phosphide. She presented with repeated vomiting, restlessness, and confusion. Upon examination, the patient was drowsy, pale, cold, and clammy. She had nonrecordable blood pressure and radial pulsation. Glasgow Coma Scale was 14/15. Routine laboratory investigations and initial electrocardiogram were normal. Six hours after intensive care unit admission, the electrocardiogram showed atrial fibrillation with fast ventricular response, ST segment elevation, and inverted T-waves. Cardiac troponin level was elevated. With the diagnosis of acute aluminum phosphide poisoning with cardiotoxicity (acute myocardial infarction), hospital-based protocol was administered and medical treatment for myocardial infarction was given. She was discharged on the fourth day after full recovery. She came for regular follow-up visits and had normal clinical evaluation, electrocardiogram, and laboratory findings.</p><p><strong>Conclusion: </strong>Exposure to phosphine gas released from aluminum phosphide fumigants increases the risk of major morbidity and mortality. The mortality due to aluminum phosphide poisoning is very high and variable. The use of magnesium sulfate to reduce cardiac arrhythmias and mortality is well documented, but there is no uniformity in dose or frequency of its administration worldwide.</p><p><strong>Limitations: </strong>One of the limitations of this report is the nature of the case report, being a retrospective design, giving no chance to establish a cause-effect relationship. Arterial blood gas analysis, serum magnesium level, and cardiac computed tomography/magnetic resonance imaging modalities were not available in the town. The recommended gastric lavage with potassium permanganate solution was not used in this case, because potassium permanganate is not available in Ethiopia. The other limitation is that, as it is a case report from a single center, it may not be representative of the general population. These limitations might have a negative impact
{"title":"Survival after aluminum phosphide poisoning with cardiotoxicity: a case report.","authors":"Habtamu Mesele Gebray, Addisu Liknaw Chekol","doi":"10.1186/s13256-024-04988-0","DOIUrl":"10.1186/s13256-024-04988-0","url":null,"abstract":"<p><strong>Introduction: </strong>Aluminum phosphide is a cheap and commonly used rodenticide that is also an effective solid fumigant and frequently used for grain preservation. The pill contains around 44% inert elements (ammonium carbonate) to avoid disintegration of the tablet, while the rest (about 56%) is aluminum phosphide. Because it is freely available on the market, it is one of the commonly used agents for self-poisoning in different parts of the developing world. Early signs of toxicity are manifested by shock and circulatory failure. Until now, no specific antidote is available. Aggressive supportive management is the key to survival in cases of aluminum phosphide poisoning.</p><p><strong>Case presentation: </strong>We present a case of successful management of aluminum phosphide poisoning-induced cardiotoxicity with a favorable outcome in a 48-year-old Black African female patient who was taken to a private clinic 6 hours after intentional ingestion of two tablets of aluminum phosphide. She presented with repeated vomiting, restlessness, and confusion. Upon examination, the patient was drowsy, pale, cold, and clammy. She had nonrecordable blood pressure and radial pulsation. Glasgow Coma Scale was 14/15. Routine laboratory investigations and initial electrocardiogram were normal. Six hours after intensive care unit admission, the electrocardiogram showed atrial fibrillation with fast ventricular response, ST segment elevation, and inverted T-waves. Cardiac troponin level was elevated. With the diagnosis of acute aluminum phosphide poisoning with cardiotoxicity (acute myocardial infarction), hospital-based protocol was administered and medical treatment for myocardial infarction was given. She was discharged on the fourth day after full recovery. She came for regular follow-up visits and had normal clinical evaluation, electrocardiogram, and laboratory findings.</p><p><strong>Conclusion: </strong>Exposure to phosphine gas released from aluminum phosphide fumigants increases the risk of major morbidity and mortality. The mortality due to aluminum phosphide poisoning is very high and variable. The use of magnesium sulfate to reduce cardiac arrhythmias and mortality is well documented, but there is no uniformity in dose or frequency of its administration worldwide.</p><p><strong>Limitations: </strong>One of the limitations of this report is the nature of the case report, being a retrospective design, giving no chance to establish a cause-effect relationship. Arterial blood gas analysis, serum magnesium level, and cardiac computed tomography/magnetic resonance imaging modalities were not available in the town. The recommended gastric lavage with potassium permanganate solution was not used in this case, because potassium permanganate is not available in Ethiopia. The other limitation is that, as it is a case report from a single center, it may not be representative of the general population. These limitations might have a negative impact","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":"18 1","pages":"614"},"PeriodicalIF":0.9,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11684319/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142903210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-29DOI: 10.1186/s13256-024-04971-9
Nazar Akhverdyan, Zachary Cantor, Kellie Hawkins
Background: Leprosy (Hansen's disease) is an infectious disease most common in resource-limited countries caused by the acid-fast bacilli Mycobacterium leprae and Mycobacterium lepromatosis that frequently affects the skin and peripheral nerves. Prompt diagnosis and treatment with multidrug therapy is crucial to reduce disease transmission and sequelae, which include nerve function impairment, ocular injury, and stigmatizing physical deformities. Traditional treatment of multibacillary leprosy consists of 12-24 months of multidrug therapy with dapsone, rifampin, and clofazimine. However, this regimen is associated with high pill burden and side effects that limit adherence.
Case presentation: We report a case of multibacillary leprosy in a previously healthy 30-year-old Hispanic man who recently immigrated to the USA from South America and presented with progressive nodular skin lesions on his face and extremities. He was treated with a monthly regimen of rifampin, moxifloxacin, and minocycline. At follow-up there was significant improvement of his cutaneous lesions without signs of reversal reaction or erythema nodosum leprosum.
Conclusions: This case report adds to the growing repertoire of literature supporting the use of rifampin, moxifloxacin, and minocycline. Further studies are needed to assess the efficacy of this antimycobacterial regimen and monitor rates of relapse and delayed immunologic reactions, which may occur 5-10 years after completion of treatment.
{"title":"An alternative multidrug regimen for multibacillary Hansen's disease: a case report.","authors":"Nazar Akhverdyan, Zachary Cantor, Kellie Hawkins","doi":"10.1186/s13256-024-04971-9","DOIUrl":"10.1186/s13256-024-04971-9","url":null,"abstract":"<p><strong>Background: </strong>Leprosy (Hansen's disease) is an infectious disease most common in resource-limited countries caused by the acid-fast bacilli Mycobacterium leprae and Mycobacterium lepromatosis that frequently affects the skin and peripheral nerves. Prompt diagnosis and treatment with multidrug therapy is crucial to reduce disease transmission and sequelae, which include nerve function impairment, ocular injury, and stigmatizing physical deformities. Traditional treatment of multibacillary leprosy consists of 12-24 months of multidrug therapy with dapsone, rifampin, and clofazimine. However, this regimen is associated with high pill burden and side effects that limit adherence.</p><p><strong>Case presentation: </strong>We report a case of multibacillary leprosy in a previously healthy 30-year-old Hispanic man who recently immigrated to the USA from South America and presented with progressive nodular skin lesions on his face and extremities. He was treated with a monthly regimen of rifampin, moxifloxacin, and minocycline. At follow-up there was significant improvement of his cutaneous lesions without signs of reversal reaction or erythema nodosum leprosum.</p><p><strong>Conclusions: </strong>This case report adds to the growing repertoire of literature supporting the use of rifampin, moxifloxacin, and minocycline. Further studies are needed to assess the efficacy of this antimycobacterial regimen and monitor rates of relapse and delayed immunologic reactions, which may occur 5-10 years after completion of treatment.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":"18 1","pages":"612"},"PeriodicalIF":0.9,"publicationDate":"2024-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11682613/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142895356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-28DOI: 10.1186/s13256-024-05002-3
Maryam Mansour, Arwa Shamasnah, Deema Alsaadi, Saja Abu Saif, Akram Krama
Background: Evans syndrome is a rare disorder characterized by the simultaneous or sequential combination of autoimmune hemolytic anemia and immunological thrombocytopenia, together with a positive direct antiglobulin test. This syndrome, which can be primary or secondary, is a rare initial manifestation of autoimmune diseases, notably systemic lupus erythematosus, with 1.7-2.7% of patients with systemic lupus erythematosus developing secondary Evans syndrome, sometimes preceding the onset of systemic lupus erythematosus symptoms.
Case presentation: A 47-year-old Middle Eastern female presented with symptoms including shortness of breath, chest pain, and weakness. Physical examination revealed pallor, pale conjunctiva, icteric sclera, tachycardia, and tachypnea. She was diagnosed with Evans syndrome owing to hemolytic anemia, thrombocytopenia, and a positive Coombs test, where initial resistance to treatment prompted intensive therapy with methylprednisolone, intravenous immunoglobulin, and rituximab. Subsequent identification of systemic lupus erythematosus on the basis of positive anti-nuclear antibodies and anti-double-stranded deoxyribonucleic acid antibodies led to treatment with mycophenolate mofetil and hydroxychloroquine. Further evaluations uncovered Hashimoto's thyroiditis and pernicious anemia, necessitating thyroxine supplementation and vitamin B12 injections.
Conclusion: Hematologic abnormalities play a crucial role in the diagnostic framework of systemic lupus erythematosus. This case highlights a patient initially diagnosed with Evans syndrome, revealing an underlying systemic lupus erythematosus. The presentation underscores the significance of hematologic manifestations as integral components of the diagnostic framework for autoimmune diseases, emphasizing the intricate relationship between Evans syndrome and systemic lupus erythematosus.
{"title":"Evans syndrome as a presentation in systemic lupus erythematous, coexisting with Hashimoto's thyroiditis and pernicious anemia: a case report.","authors":"Maryam Mansour, Arwa Shamasnah, Deema Alsaadi, Saja Abu Saif, Akram Krama","doi":"10.1186/s13256-024-05002-3","DOIUrl":"10.1186/s13256-024-05002-3","url":null,"abstract":"<p><strong>Background: </strong>Evans syndrome is a rare disorder characterized by the simultaneous or sequential combination of autoimmune hemolytic anemia and immunological thrombocytopenia, together with a positive direct antiglobulin test. This syndrome, which can be primary or secondary, is a rare initial manifestation of autoimmune diseases, notably systemic lupus erythematosus, with 1.7-2.7% of patients with systemic lupus erythematosus developing secondary Evans syndrome, sometimes preceding the onset of systemic lupus erythematosus symptoms.</p><p><strong>Case presentation: </strong>A 47-year-old Middle Eastern female presented with symptoms including shortness of breath, chest pain, and weakness. Physical examination revealed pallor, pale conjunctiva, icteric sclera, tachycardia, and tachypnea. She was diagnosed with Evans syndrome owing to hemolytic anemia, thrombocytopenia, and a positive Coombs test, where initial resistance to treatment prompted intensive therapy with methylprednisolone, intravenous immunoglobulin, and rituximab. Subsequent identification of systemic lupus erythematosus on the basis of positive anti-nuclear antibodies and anti-double-stranded deoxyribonucleic acid antibodies led to treatment with mycophenolate mofetil and hydroxychloroquine. Further evaluations uncovered Hashimoto's thyroiditis and pernicious anemia, necessitating thyroxine supplementation and vitamin B12 injections.</p><p><strong>Conclusion: </strong>Hematologic abnormalities play a crucial role in the diagnostic framework of systemic lupus erythematosus. This case highlights a patient initially diagnosed with Evans syndrome, revealing an underlying systemic lupus erythematosus. The presentation underscores the significance of hematologic manifestations as integral components of the diagnostic framework for autoimmune diseases, emphasizing the intricate relationship between Evans syndrome and systemic lupus erythematosus.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":"18 1","pages":"643"},"PeriodicalIF":0.9,"publicationDate":"2024-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11682623/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142895363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-28DOI: 10.1186/s13256-024-04974-6
Abdulla Abdelwahab, Ahmed Khairy Farahat Elsayed, Hamed Badawi
Background: Open and crushed forearm injury is a complex and rare injury affecting the upper extremity. It results in damage to various structures, including bones, soft tissues, and neurovascular bundles, ultimately leading to functional impairment. Typically, these injuries occur owing to high-energy trauma.
Case presentation: A 19-year-old South Asian male was seen at our trauma center emergency department following an accident where his arm got entangled in a machine belt. He sustained a serious open injury on his left forearm, spanning from the elbow to the wrist, affecting the proximal radio-ulnar joint, ulna bone, interosseous membrane, and distal radio-ulnar joint. The initial plan of care involved stabilizing the injury using an external fixator, while reconstructive surgery was scheduled for a later date.
Conclusion: Timely intervention for wound debridement and joint stabilization plays a crucial role in the restoration of a crushed forearm. Following this, a collaborative effort from a multidisciplinary team becomes essential. Planning multiple surgeries is important, with the primary goal of achieving early range of motion of the elbow and wrist to prevent stiffness. This comprehensive approach aims at optimizing the recovery and functionality of the affected limb. The combination of early intervention, damage control surgeries, and carefully planned procedures sets the foundation for successful management of a crushed and open forearm injury. Furthermore, early range of motion and physiotherapy rehabilitation has a key role in stiffness prevention and the restoration of function.
{"title":"A staged approach to managing a combination of a terrible triad injury and an Essex-Lopresti fracture dislocation: an open forearm crush injury-a case report.","authors":"Abdulla Abdelwahab, Ahmed Khairy Farahat Elsayed, Hamed Badawi","doi":"10.1186/s13256-024-04974-6","DOIUrl":"10.1186/s13256-024-04974-6","url":null,"abstract":"<p><strong>Background: </strong>Open and crushed forearm injury is a complex and rare injury affecting the upper extremity. It results in damage to various structures, including bones, soft tissues, and neurovascular bundles, ultimately leading to functional impairment. Typically, these injuries occur owing to high-energy trauma.</p><p><strong>Case presentation: </strong>A 19-year-old South Asian male was seen at our trauma center emergency department following an accident where his arm got entangled in a machine belt. He sustained a serious open injury on his left forearm, spanning from the elbow to the wrist, affecting the proximal radio-ulnar joint, ulna bone, interosseous membrane, and distal radio-ulnar joint. The initial plan of care involved stabilizing the injury using an external fixator, while reconstructive surgery was scheduled for a later date.</p><p><strong>Conclusion: </strong>Timely intervention for wound debridement and joint stabilization plays a crucial role in the restoration of a crushed forearm. Following this, a collaborative effort from a multidisciplinary team becomes essential. Planning multiple surgeries is important, with the primary goal of achieving early range of motion of the elbow and wrist to prevent stiffness. This comprehensive approach aims at optimizing the recovery and functionality of the affected limb. The combination of early intervention, damage control surgeries, and carefully planned procedures sets the foundation for successful management of a crushed and open forearm injury. Furthermore, early range of motion and physiotherapy rehabilitation has a key role in stiffness prevention and the restoration of function.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":"18 1","pages":"642"},"PeriodicalIF":0.9,"publicationDate":"2024-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11681685/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142895353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Tropheryma whipplei pneumonia is an infrequent medical condition. The clinical symptoms associated with this disease are nonspecific, often resulting in misdiagnosis or missed diagnosis. Therefore, sharing and summarizing the experiences in the diagnosis and treatment of this disease can deepen global understanding and awareness of it.
Case presentation: The patient is a 78-year-old married Han Chinese female who was admitted to the hospital after experiencing fever, dry cough, and fatigue for 4 days. A lung computed tomography scan revealed inflammatory exudation in the lower left lung, accompanied by pleural effusion. The bronchoalveolar lavage fluid was subjected to further analysis using metagenomic next-generation sequencing, which identified 41 genetic sequences associated with Tropheryma whipplei. Consequently, she was diagnosed with Tropheryma whipplei pneumonia. After initiating treatment with doxycycline and biapenem, the patient's symptoms showed significant improvement. Upon discharge, the patient continued treatment with a combination of doxycycline and hydroxychloroquine, which was discontinued after 4 days. At 12-month follow-up, the patient reported overall good health, with no symptoms of fever, cough, or any other discomfort.
Conclusion: Tropheryma whipplei pneumonia is a rare condition with nonspecific symptoms. The application of metagenomic next-generation sequencing technology in pulmonary infections helps to rapidly identify rare pathogens, providing a solid foundation for precise and effective antibacterial treatment for patients.
{"title":"Pulmonary infection caused by Tropheryma whipplei: a case report and review of the literature.","authors":"Jianglong Shi, Ren Liu, Jiehui Qiu, Chunping Wei, Dejin Pan, Tianxin Xiang, Na Cheng","doi":"10.1186/s13256-024-04936-y","DOIUrl":"10.1186/s13256-024-04936-y","url":null,"abstract":"<p><strong>Background: </strong>Tropheryma whipplei pneumonia is an infrequent medical condition. The clinical symptoms associated with this disease are nonspecific, often resulting in misdiagnosis or missed diagnosis. Therefore, sharing and summarizing the experiences in the diagnosis and treatment of this disease can deepen global understanding and awareness of it.</p><p><strong>Case presentation: </strong>The patient is a 78-year-old married Han Chinese female who was admitted to the hospital after experiencing fever, dry cough, and fatigue for 4 days. A lung computed tomography scan revealed inflammatory exudation in the lower left lung, accompanied by pleural effusion. The bronchoalveolar lavage fluid was subjected to further analysis using metagenomic next-generation sequencing, which identified 41 genetic sequences associated with Tropheryma whipplei. Consequently, she was diagnosed with Tropheryma whipplei pneumonia. After initiating treatment with doxycycline and biapenem, the patient's symptoms showed significant improvement. Upon discharge, the patient continued treatment with a combination of doxycycline and hydroxychloroquine, which was discontinued after 4 days. At 12-month follow-up, the patient reported overall good health, with no symptoms of fever, cough, or any other discomfort.</p><p><strong>Conclusion: </strong>Tropheryma whipplei pneumonia is a rare condition with nonspecific symptoms. The application of metagenomic next-generation sequencing technology in pulmonary infections helps to rapidly identify rare pathogens, providing a solid foundation for precise and effective antibacterial treatment for patients.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":"18 1","pages":"613"},"PeriodicalIF":0.9,"publicationDate":"2024-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11681769/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142895391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-27DOI: 10.1186/s13256-024-04852-1
Yungee Jung, Anthony Lau, Joseph Bednarczyk
Background: Immunotherapy, including the use of immune checkpoint inhibitors such as nivolumab, is increasingly common in cancer treatment and can lead to various immune-related adverse effects, including rare cases of diabetic ketoacidosis. This case report highlights an unique instance of nivolumab-induced diabetic ketoacidosis in a patient without prior history of diabetes, emphasizing the importance of careful monitoring even in those without traditional risk factors.
Case presentation: We report a case of a 70-year-old Caucasian male with metastatic esophageal adenocarcinoma who developed diabetic ketoacidosis 3 weeks after stopping nivolumab therapy. The patient had no previous history of diabetes, nor had he used sodium-glucose transport protein 2 inhibitors or corticosteroids. Diagnostic tests confirmed diabetic ketoacidosis, and while he was initially treated following the institutional protocol, he continued to require insulin therapy indefinitely.
Conclusions: This case report underscores the risk of diabetic ketoacidosis linked to nivolumab, even in patients without predisposing factors, emphasizing the need for increased vigilance among both oncologists and physicians. It highlights the importance of monitoring for new-onset diabetes and diabetic ketoacidosis, whether immunotherapy is active or discontinued, and ensuring comprehensive care including hospitalization, insulin management, and diabetes education if diabetic ketoacidosis is diagnosed.
{"title":"Immune checkpoint inhibitor-associated diabetic ketoacidosis and insulin-dependent diabetes: a case report.","authors":"Yungee Jung, Anthony Lau, Joseph Bednarczyk","doi":"10.1186/s13256-024-04852-1","DOIUrl":"10.1186/s13256-024-04852-1","url":null,"abstract":"<p><strong>Background: </strong>Immunotherapy, including the use of immune checkpoint inhibitors such as nivolumab, is increasingly common in cancer treatment and can lead to various immune-related adverse effects, including rare cases of diabetic ketoacidosis. This case report highlights an unique instance of nivolumab-induced diabetic ketoacidosis in a patient without prior history of diabetes, emphasizing the importance of careful monitoring even in those without traditional risk factors.</p><p><strong>Case presentation: </strong>We report a case of a 70-year-old Caucasian male with metastatic esophageal adenocarcinoma who developed diabetic ketoacidosis 3 weeks after stopping nivolumab therapy. The patient had no previous history of diabetes, nor had he used sodium-glucose transport protein 2 inhibitors or corticosteroids. Diagnostic tests confirmed diabetic ketoacidosis, and while he was initially treated following the institutional protocol, he continued to require insulin therapy indefinitely.</p><p><strong>Conclusions: </strong>This case report underscores the risk of diabetic ketoacidosis linked to nivolumab, even in patients without predisposing factors, emphasizing the need for increased vigilance among both oncologists and physicians. It highlights the importance of monitoring for new-onset diabetes and diabetic ketoacidosis, whether immunotherapy is active or discontinued, and ensuring comprehensive care including hospitalization, insulin management, and diabetes education if diabetic ketoacidosis is diagnosed.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":"18 1","pages":"611"},"PeriodicalIF":0.9,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11673709/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142895376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}